Topic: Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcin

Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.

http://www.nature.com/bjc/journal/vaop/ … 3655a.html

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.